33
|
Macara IG, Baldarelli R, Field CM, Glotzer M, Hayashi Y, Hsu SC, Kennedy MB, Kinoshita M, Longtine M, Low C, Maltais LJ, McKenzie L, Mitchison TJ, Nishikawa T, Noda M, Petty EM, Peifer M, Pringle JR, Robinson PJ, Roth D, Russell SH, Stuhlmann H, Tanaka M, Tanaka T, Trimble WS, Ware J, Zeleznik-Le NJ, Zieger B. Mammalian septins nomenclature. Mol Biol Cell 2002; 13:4111-3. [PMID: 12475938 PMCID: PMC138619 DOI: 10.1091/mbc.e02-07-0438] [Citation(s) in RCA: 91] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
There are 10 known mammalian septin genes, some of which produce multiple splice variants. The current nomenclature for the genes and gene products is very confusing, with several different names having been given to the same gene product and distinct names given to splice variants of the same gene. Moreover, some names are based on those of yeast or Drosophila septins that are not the closest homologues. Therefore, we suggest that the mammalian septin field adopt a common nomenclature system, based on that adopted by the Mouse Genomic Nomenclature Committee and accepted by the Human Genome Organization Gene Nomenclature Committee. The human and mouse septin genes will be named SEPT1-SEPT10 and Sept1-Sept10, respectively. Splice variants will be designated by an underscore followed by a lowercase "v" and a number, e.g., SEPT4_v1.
Collapse
Affiliation(s)
- Ian G. Macara
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Richard Baldarelli
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Christine M. Field
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Michael Glotzer
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Yasuhide Hayashi
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Shu-Chan Hsu
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Mary B. Kennedy
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Makoto Kinoshita
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Mark Longtine
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Claudia Low
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Lois J. Maltais
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Louise McKenzie
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Timothy J. Mitchison
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Toru Nishikawa
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Makoto Noda
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Elizabeth M. Petty
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Mark Peifer
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - John R. Pringle
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Phillip J. Robinson
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Dagmar Roth
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - S.E. Hilary Russell
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Heidi Stuhlmann
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Manami Tanaka
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Tomoo Tanaka
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - William S. Trimble
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Jerry Ware
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Nancy J. Zeleznik-Le
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| | - Barbara Zieger
- Center for Cell Signaling, University of Virginia School of
Medicine, Charlottesville, Virginia 22908; Mouse Genome
Informatics, Jackson Laboratories, Bar Harbor, Maine 04609;
Department of Cell Biology, Harvard Medical School,
Boston, Massachusetts 02115; Research Institute of
Molecular Pathology, A-1030 Vienna, Austria; Department
of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo
113-8655, Japan; Department of Cell Biology and
Neuroscience, Rutgers University, Piscataway, New Jersey 08854;
Division of Biology, California Institute of Technology,
Pasadena, California 91125; Department of Biochemistry and Molecular
Biology, Oklahoma State University, Stillwater, Oklahoma 74078;
Department of Biochemistry, University of Virginia
School of Medicine, Charlottesville, Virginia 22908;
Section of Psychiatry and Behavioral Sciences, Tokyo
Medical and Dental University Graduate School, 1-5-45, Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan; Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan 48109; Department of
Biology, University of North Carolina, Chapel Hill, North Carolina
27599; Cell Signaling Unit, Children's Medical Research
Institute, Wentworthville 2145, New South Wales, Australia;
Max-Planck-Institute for Brain Research, Department of
Neurochemistry, Frankfurt, and Covidence GmbH, Philipp-Helfmann-Strasse
18, D-65760 Eschborn, Germany; Department of Oncology, Queen's
University of Belfast, Belfast BT9 7AB, United Kingdom;
Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, New York 10029;
National Institute of Advanced Industrial Science
and Technology, Bldg. Tsukuba Central 6, Higashi, Tsukuba Science City,
Ibaraki 305-8566, Japan; Tokai University
School of Medicine, Isehara, Kanagawa 259-1193, Japan;
Program in Cell Biology, Hospital for Sick
Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada;
The Scripps Research Institute, La Jolla, California
92037; Cardinal Bernardin Cancer Center and Department
of Medicine, Loyola University Medical, Center, Maywood, Illinois
60153; and Department of Pediatrics and
Adolescent Medicine, Children's Hospital, University of
Freiburg, D-79106 Freiburg, Germany
| |
Collapse
|